Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Progress in Biophysics and Molecular Biology
|
October 21, 2024
Nuclear membrane: A key potential therapeutic target for lipid metabolism
Min Zeng, Longgui Chen, YaZhu Wang
Cancer Gene Therapy
|
July 7, 2026
VPS37A loss creates CASP8-dependent vulnerability via the MAP3K7-NF-κB-CFLAR axis
Tatsuya Hattori, Longgui Chen, Xinwen Liang, et al.
Cell Death & Disease
|
September 9, 2016
Atg5-dependent autophagy contributes to the development of acute myeloid leukemia in an MLL-AF9-driven mouse model
Qiang Liu, Longgui Chen, Jennifer M Atkinson, et al.
Biomedicines
|
November 27, 2024
Identification of Contactin-1 as a Potential Biomarker and Therapeutic Target in Neuroblastoma
Christa N Grant, Carson A Wills, Xiaoming Liu, et al.
Cell Death and Differentiation
|
August 19, 2020
Targeting the ESCRT-III component CHMP2A for noncanonical Caspase-8 activation on autophagosomal membranes
Tatsuya Hattori, Yoshinori Takahashi, Longgui Chen, et al.
Cancer Research
|
October 29, 2020
Chemotherapy-Induced Upregulation of Small Extracellular Vesicle-Associated PTX3 Accelerates Breast Cancer Metastasis
Carson A Wills, Xiaoming Liu, Longgui Chen, et al.
Molecular Cancer Therapeutics
|
September 1, 2018
Targeted Inhibition of ULK1 Promotes Apoptosis and Suppresses Tumor Growth and Metastasis in Neuroblastoma
Christopher M Dower, Neema Bhat, Melat T Gebru, et al.
Oncogene
|
April 24, 2026
Targeting VPS4 elicits STING-driven anti-tumor immunity to suppress rhabdomyosarcoma growth
Ray Zhang, Longgui Chen, Xinwen Liang, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 27, 2025
DBeQ derivative targets vacuolar protein sorting 4 functions in cancer cells and suppresses tumor growth in mice
Kevin A Fundora, Yan Zhuang, Kouta Hamamoto, et al.
Journal for Immunotherapy of Cancer
|
April 28, 2022
Small extracellular vesicles induce resistance to anti-GD2 immunotherapy unveiling tipifarnib as an adjunct to neuroblastoma immunotherapy
Xiaoming Liu, Carson A Wills, Longgui Chen, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Progress in Biophysics and Molecular Biology
|
October 21, 2024
Nuclear membrane: A key potential therapeutic target for lipid metabolism
Min Zeng, Longgui Chen, YaZhu Wang
Cancer Gene Therapy
|
July 7, 2026
VPS37A loss creates CASP8-dependent vulnerability via the MAP3K7-NF-κB-CFLAR axis
Tatsuya Hattori, Longgui Chen, Xinwen Liang, et al.
Cell Death & Disease
|
September 9, 2016
Atg5-dependent autophagy contributes to the development of acute myeloid leukemia in an MLL-AF9-driven mouse model
Qiang Liu, Longgui Chen, Jennifer M Atkinson, et al.
Biomedicines
|
November 27, 2024
Identification of Contactin-1 as a Potential Biomarker and Therapeutic Target in Neuroblastoma
Christa N Grant, Carson A Wills, Xiaoming Liu, et al.
Cell Death and Differentiation
|
August 19, 2020
Targeting the ESCRT-III component CHMP2A for noncanonical Caspase-8 activation on autophagosomal membranes
Tatsuya Hattori, Yoshinori Takahashi, Longgui Chen, et al.
Cancer Research
|
October 29, 2020
Chemotherapy-Induced Upregulation of Small Extracellular Vesicle-Associated PTX3 Accelerates Breast Cancer Metastasis
Carson A Wills, Xiaoming Liu, Longgui Chen, et al.
Molecular Cancer Therapeutics
|
September 1, 2018
Targeted Inhibition of ULK1 Promotes Apoptosis and Suppresses Tumor Growth and Metastasis in Neuroblastoma
Christopher M Dower, Neema Bhat, Melat T Gebru, et al.
Oncogene
|
April 24, 2026
Targeting VPS4 elicits STING-driven anti-tumor immunity to suppress rhabdomyosarcoma growth
Ray Zhang, Longgui Chen, Xinwen Liang, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 27, 2025
DBeQ derivative targets vacuolar protein sorting 4 functions in cancer cells and suppresses tumor growth in mice
Kevin A Fundora, Yan Zhuang, Kouta Hamamoto, et al.
Journal for Immunotherapy of Cancer
|
April 28, 2022
Small extracellular vesicles induce resistance to anti-GD2 immunotherapy unveiling tipifarnib as an adjunct to neuroblastoma immunotherapy
Xiaoming Liu, Carson A Wills, Longgui Chen, et al.
Page
of 2